Neurol. pro Praxi, 2006; 1: 9-12

Amyotrofická laterální skleróza

prof. MUDr. Zdeněk Ambler, DrSc.
Neonatologické oddělení, FN a LF UK, Plzeň

Amyotrofická laterální skleróza, nemoc motoneuronu, je degenerativní onemocnění s progresivním zánikem motoneuronů předních rohů míšních, kortexu, jader motorických hlavových nervů v bulbární oblasti a degenerací motorické kortikospinální dráhy. Vyskytuje se převážně ve formě sporadické, v 5–10 % jako familiární dědičná forma. Typickým obrazem je smíšené postižení centrálního i periferního motoneuronu (svalové atrofie, fascikulace, současně zvýšené šlachookosticové reflexy a spastické jevy) a neporušená citlivost. V článku jsou shrnuty hlavní uvažované patogenetické mechanizmy, klinické projevy, diagnostická kritéria včetně elektrodiagnostiky, diferenciální diagnóza a terapie.

Keywords: nemoc motoneuronu, neurodegenerace, elektrodiagnostika, elektromyografie

Published: January 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ambler Z. Amyotrofická laterální skleróza. Neurol. praxi. 2006;7(1):9-12.
Download citation

References

  1. Clem K, Morgenlander JC. Amyotrophic Lateral Sclerosis. E-Medicine. Last Updated: September 9, 2004. www.emedicine.com.
  2. Cleveland DW, Rothstein JD. From Charcot to Lou Gehrig: Deciphering selective motor neuron death in ALS. Nat Rev Neurosci 2001; 2: 806-819. Go to original source... Go to PubMed...
  3. CONTINUUM - Amyotrophic lateral sclerosis. American Academy of Neurology, Minneapolis, USA, 2002; 8: 227.
  4. Goetz CG. Amyotrophic lateral sclerosis: Early contributions of Jean-Martin Charcot. Muscle Nerve 2000; 23: 336-343. Go to original source...
  5. Miller RG, Mitchell JD, Lyon M and Moore DH. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND) (Cochrane Review). In: The Cochrane Library, Issue 4, 2005. Oxford: Update Software.
  6. Miller RG, Rosenberg JA, Gelinas DF, et al. Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology: ALS Practice Parameters Task Force. Neurology 1999 Apr 22; 52(7): 1311-23. Go to original source... Go to PubMed...
  7. Mitsumoto H, Chad D, Pioro EP. Amyotrophic Lateral Sclerosis. Contemporary Neurology Series, FA Davis, Philadelphia 1997. Go to original source...
  8. Murray B, Mitsumoto H. Disorders of Upper and Lower Motor Neurons. Neurology in Clinical Practice, 4th ed., Ed. WG Bradley, RB Daroff, GM Fenichel, J Jankovic. Butterworth-Heinemann, 2004: p. 2246-2260.
  9. Oliver D, Borasio GD, Walsh D eds. Palliative Care in Amyotrophic Lateral Sclerosis. Oxford, Oxford University Press; 2000.
  10. Swash M. Clinical features and diagnosis of amyotrophic lateral sclerosis. In: Brown RH, Meininger V, Swash M (eds). Amyotrophic lateral sclerosis. London: Martin Dunitz, 2000. Go to original source...
  11. World Federation of Neurology Research Group on Neuromuscular Diseases. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. J Neurol Sci 1994; 124 (Suppl): 96-107. www.wfnals.org/guidelines/index.html Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.